Document is current
Any future updates will be listed below
-
Authors
Seif El Dahan, Karim
Yokoo, Takeshi
Mendiratta-Lala, Mishal
Fetzer, David
Davenport, Matthew
Daher, Darine
Rich, Nicole E.
Yang, Edward
Parikh, Neehar D.
Singal, Amit G.
-
Funding
Funding for this research was provided by:
Cancer Prevention and Research Institute of Texas (RP210041)
National Institutes of Health (K08CA259536, U01 CA271887)
- License Information
-
More Information
Article History
Received: 24 August 2024
Revised: 31 October 2024
Accepted: 2 November 2024
First Online: 15 November 2024
Declarations
:
: Amit Singal has served as a consultant or on advisory boards for Bayer, FujiFilm Medical Sciences, Exact Sciences, Universal Dx, Glycotest, Roche, Freenome, Delfi, GRAIL, Genentech, AstraZeneca, Eisai, Exelixis, Boston Scientific, HistoSonics. Neehar Parikh has served as a consultant or on advisory boards for Bayer, FujiFilm Medical Sciences, Exact Sciences, Glycotest, and Freenome. Matthew Davenport is a consultant for Covera Health, Treasurer for the Society of Advanced Body Imaging, and receives royalties from Wolters Kluwer.Nicole Rich has served as consultant for AstraZeneca.David Fetzer has served on the advisor board for GE HealthCare and Philips Healthcare, and has active research agreements with GE HealthCare, Philips Healthcare, and Siemens Healthineers.Takeshi Yokoo has served on an advisory board of Guerbet and the speaker panels for Siemens Healthineers and Northwest Imaging, as well as active research agreements with Siemens Healthineers.
